Forward-looking Statements
The following discussion of the Company's financial condition and results of
operations should be read together with TD Group's condensed consolidated
financial statements and the related notes included elsewhere in this Quarterly
Report on Form 10-Q. References in this section to "TransDigm," "the Company,"
"we," "us," "our," and similar references refer to TD Group, TransDigm, Inc. and
TransDigm, Inc.'s subsidiaries, unless the context otherwise indicates.
This Quarterly Report on Form 10-Q contains both historical and "forward-looking
statements" within the meaning of Section 21E of the Exchange Act, and 27A of
the Securities Act. All statements other than statements of historical fact
included that address activities, events or developments that we expect, believe
or anticipate will or may occur in the future are forward-looking statements,
including, in particular, the statements about our plans, objectives, strategies
and prospects regarding, among other things, our financial condition, results of
operations and business. We have identified some of these forward-looking
statements with words like "believe," "may," "will," "should," "expect,"
"intend," "plan," "predict," "anticipate," "estimate" or "continue" and other
words and terms of similar meaning. These forward-looking statements may be
contained throughout this Quarterly Report on Form 10-Q. These forward-looking
statements are based on current expectations about future events affecting us
and are subject to uncertainties and factors relating to, among other things,
our operations and business environment, all of which are difficult to predict
and many of which are beyond our control. Many factors mentioned in our
discussion in this Quarterly Report on Form 10-Q, including the risks outlined
under "Risk Factors," will be important in determining future results. Although
we believe that the expectations reflected in these forward-looking statements
are reasonable, we do not know whether our expectations will prove correct. They
can be affected by inaccurate assumptions we might make or by known or unknown
risks and uncertainties, including those described under "Risk Factors" in the
Quarterly Report on Form 10-Q. Since our actual results, performance or
achievements could differ materially from those expressed in, or implied by,
these forward-looking statements, we cannot give any assurance that any of the
events anticipated by these forward-looking statements will occur or, if any of
them does occur, what impact they will have on our business, results of
operations and financial condition. You are cautioned not to place undue
reliance on these forward-looking statements, which speak only as of the date
they are made. We do not undertake any obligation to update these
forward-looking statements or the risk factors contained in this Quarterly
Report on Form 10-Q to reflect new information, future events or otherwise,
except as may be required under federal securities laws.
Important factors that could cause actual results to differ materially from the
forward-looking statements made in this Quarterly Report on Form 10-Q include
but are not limited to: the impact that the COVID-19 pandemic has on our
business, results of operations, financial condition and liquidity; the
sensitivity of our business to the number of flight hours that our customers'
planes spend aloft and our customers' profitability, both of which are affected
by general economic conditions; future geopolitical or other worldwide events;
cyber-security threats and natural disasters; our reliance on certain customers;
the U.S. defense budget and risks associated with being a government supplier
including government audits and investigations; failure to maintain government
or industry approvals; failure to complete or successfully integrate
acquisitions; our indebtedness; potential environmental liabilities; liabilities
arising in connection with litigation; increases in raw material costs, taxes
and labor costs that cannot be recovered in product pricing; risks and costs
associated with our international sales and operations; and other factors. Refer
to Item 1A included in this Quarterly Report on Form 10-Q and to Item 1A of the
Annual Report on Form 10-K for additional information regarding the foregoing
factors that may affect our business.
Overview
We believe we are a leading global designer, producer and supplier of highly
engineered proprietary aerospace components with significant aftermarket
content. We seek to develop highly customized products to solve specific needs
for aircraft operators and manufacturers. We attempt to differentiate ourselves
based on engineering, service and manufacturing capabilities. We typically
choose not to compete for non-proprietary "build to print" business because it
frequently offers lower margins than proprietary products. We believe that our
products have strong brand names within the industry and that we have a
reputation for high quality, reliability and strong customer support. Our
business is well diversified due to the broad range of products that we offer to
our customers. Our major product offerings, substantially all of which are
ultimately provided to end-users in the aerospace industry, include
mechanical/electro-mechanical actuators and controls, ignition systems and
engine technology, specialized pumps and valves, power conditioning devices,
specialized AC/DC electric motors and generators, batteries and chargers,
engineered latching and locking devices, engineered rods, engineered connectors
and elastomer sealing solutions, databus and power controls, cockpit security
components and systems, specialized and advanced cockpit displays, engineered
audio, radio and antenna systems, specialized lavatory components, seat belts
and safety restraints, engineered and customized interior surfaces and related
components, advanced sensor products, switches and relay panels, thermal
protection and insulation, lighting and control technology, parachutes, high
performance hoists, winches and lifting devices, and cargo loading, handling and
delivery systems. Each of these product offerings is composed of many individual
products that are typically customized to meet the needs of a particular
aircraft platform or customer.
                                       27
--------------------------------------------------------------------------------
  Table of Contents
For the second quarter of fiscal year 2021, we generated net sales of $1,194
million and net income attributable to TD Group of $104 million. EBITDA As
Defined was $519 million, or 43.5% of net sales. Refer to the "Non-GAAP
Financial Measures" section for certain information regarding EBITDA and EBITDA
As Defined, including reconciliations of EBITDA and EBITDA As Defined to income
from continuing operations and net cash provided by operating activities.
COVID-19 was first reported in December 2019, and since being declared as a
pandemic by the World Health Organization in March 2020, has dramatically
impacted the global health and economic environment, including millions of
confirmed cases, business slowdowns or shutdowns, government challenges and
market volatility. The commercial aerospace industry, in particular, has been
significantly disrupted, both domestically and internationally, by the pandemic.
The pandemic has resulted in governments around the world implementing stringent
measures to help control the spread of the virus, including quarantines,
"shelter in place" and "stay at home" orders, travel restrictions, business
curtailments and other measures. As a result, demand for travel declined at a
rapid pace beginning in the second half of fiscal 2020 and has remained
significantly depressed compared to pre-pandemic levels.
Although commercial air travel demand has shown slight signs of recovery in
recent months, the recovery is expected to continue to be slow and uneven
depending on factors such as the trends in the number of COVID-19 infections
(e.g., impact of new variants of COVID-19 surfacing), the rollout and
effectiveness of the vaccine, and the eventual easing of quarantines and travel
restrictions, among other factors. The exact timing and pace of the recovery is
indeterminable as certain markets have reopened, some of which have since
experienced a resurgence of COVID-19 cases, and in recent months new variants of
COVID-19 have been identified, resulting in additional restrictions put in place
by certain governments around the world.
Within the United States, our business has been designated as "essential," which
has allowed us to continue to serve our customers; nonetheless, the COVID-19
pandemic has significantly disrupted our operations. The outbreak of COVID-19
has heightened the risk that a significant portion of our workforce will suffer
illness or otherwise be unable to work. Furthermore, in light of enacted and any
additional reductions in our workforce as a result of declines in our business
caused by the COVID-19 pandemic, we cannot assure that we will be able to rehire
our workforce once our business has begun to recover. Certain of our facilities
have experienced temporary disruptions as a result of the COVID-19 pandemic, and
we cannot predict whether our facilities will experience more significant
disruptions in the future. Finally, our acquisition strategy, which is a key
element of our overall business strategy, may be impacted by our efforts to
maintain the Company's cash liquidity position in response to the COVID-19
pandemic depending on the duration of the pandemic and its impact on our cash
flows.
The COVID-19 pandemic has caused a significant adverse impact on our sales, net
income and EBITDA as Defined and is expected to continue to do so for at least
the remainder of fiscal 2021. This is under the assumption that the COVID-19
pandemic will continue to adversely impact customer demand for all market
channels with commercial OEM and commercial aftermarket being the most adversely
impacted due to the pandemic's impact on air travel worldwide. The defense
market channel is also impacted to a significantly lesser extent due to certain
supply chain disruptions as well as the "stay at home" orders, quarantines, etc.
impacting the government procurement workforce. Also, government funding
reprioritization such as shifting funds to efforts to combat the impact of the
pandemic provides for uncertainty. The magnitude of the impact of COVID-19
remains unpredictable and we, therefore, continue to anticipate potential supply
chain disruptions, employee absenteeism and short-term suspensions of
manufacturing facilities, and additional health and safety costs related to the
COVID-19 pandemic that could unfavorably impact our business. Longer term,
because the duration of the pandemic is unclear, it is difficult to forecast a
precise impact on the Company's future results.
The Company took immediate and aggressive action to minimize the spread of
COVID-19 in our workplaces and reduce costs. Since the early days of the
pandemic, we have been following guidance from the World Health Organization and
the U.S. Center for Disease Control to protect employees and prevent the spread
of the virus within all of our facilities globally. Some of the actions
implemented include: flexible work-from-home scheduling; alternate shift
schedules; pre-shift temperature screenings, where allowed by law; social
distancing; appropriate personal protective equipment; facility deep cleaning;
and paid quarantine time for impacted employees. In recent months, the Company
has taken various steps to facilitate access to vaccines for our employees in
accordance with federal guidelines and state and local vaccination plans.
Material actions to reduce costs in response to the impact that the pandemic has
had on operating results include: (1) reducing the Company's workforce to align
operations with customer demand through a reduction in force or through a
realignment of certain business units; (2) implementing unpaid furloughs and
salary reductions; (3) delaying non-essential capital projects and (4)
minimizing discretionary spending.
                                       28
--------------------------------------------------------------------------------
  Table of Contents
For the thirteen week period ended April 3, 2021, COVID-19 restructuring costs
of approximately $17 million were incurred, of which $14 million was recorded in
cost of sales and $3 million was recorded in selling and administrative expenses
on the condensed consolidated statements of income. For the twenty-six week
period ended April 3, 2021, COVID-19 restructuring costs of approximately $36
million were incurred, of which $26 million was recorded in cost of sales and
$10 million was recorded in selling and administrative expenses on the condensed
consolidated statements of income. These costs are primarily related to the
Company's actions to reduce its workforce and consolidate certain facilities to
align with customer demand. Additionally, for the thirteen and twenty-six week
periods ended April 3, 2021, the Company incurred approximately $1 million and
$3 million, respectively, in incremental costs related to the pandemic that are
not expected to recur once the pandemic has subsided and are clearly separable
from normal operations (e.g., additional cleaning and disinfecting of facilities
by contractors above and beyond normal requirements, personal protective
equipment, etc.). For the thirteen and twenty-six week periods ended March 28,
2020, the Company incurred approximately $1 million of restructuring costs.
As of April 3, 2021 and September 30, 2020, the restructuring accrual associated
with the costs incurred in response to the COVID-19 pandemic was approximately
$32 million and $13 million, respectively. This accrual is recorded as a
component of accrued and other current liabilities on the condensed consolidated
balance sheets. The increase in the accrual is primarily driven by costs to
reduce its workforce that have been incurred but not paid; partially offset by
payments against the accrual. The Company expects to incur additional
restructuring and incremental costs related to the COVID-19 pandemic though at a
reduced level in comparison to fiscal 2020. The Company continues to analyze its
cost structure and may implement additional cost reduction measures as necessary
due to the ongoing business challenges resulting from the COVID-19 pandemic.
Critical Accounting Policies and Estimates
The preparation and fair presentation of the consolidated unaudited interim
financial statements and accompanying notes included in this report are the
responsibility of management. The financial statements and footnotes have been
prepared in conformity with generally accepted accounting principles in the
United States ("U.S. GAAP") for interim financial statements and contain certain
amounts that were based upon management's best estimates, judgments and
assumptions that were believed to be reasonable under the circumstances. On an
ongoing basis, we evaluate the accounting policies and estimates used to prepare
financial statements. Estimates are based on historical experience, judgments
and assumptions believed to be reasonable under current facts and circumstances.
Actual amounts and results could differ from these estimates used by management.
A comprehensive discussion of the Company's critical accounting policies and
management estimates and significant accounting policies followed in the
preparation of the financial statements is included in Item 7 of our Annual
Report on Form 10-K for the fiscal year ended September 30, 2020. Other than the
adoption of ASU 2016-13 "Financial Instruments - Credit Losses: Measurement of
Credit Losses on Financial Instruments," there have been no significant changes
in critical accounting policies, management estimates or accounting policies
since the fiscal year ended September 30, 2020. Refer to Note 4, "Recent
Accounting Pronouncements," and Note 5, "Revenue Recognition," in the notes to
the condensed consolidated financial statements included herein for further
disclosure of accounting standards recently adopted or required to be adopted in
the future.
Acquisitions and Divestitures
Recent acquisitions and divestitures are described in Note 3, "Acquisitions and
Divestitures," in the notes to the condensed consolidated financial statements
included herein.
                                       29
--------------------------------------------------------------------------------
  Table of Contents
Results of Operations
The following table sets forth, for the periods indicated, certain operating
data of the Company, including presentation of the amounts as a percentage of
net sales (amounts in millions):
                                                                            

Thirteen Week Periods Ended


                                                 April 3, 2021             % of Sales             March 28, 2020             % of Sales
Net sales                                       $       1,194                     100.0  %       $        1,443                     100.0  %
Cost of sales                                             602                      50.4  %                  625                      43.3  %
Selling and administrative expenses                       162                      13.6  %                  180                      12.5  %
Amortization of intangible assets                          36                       3.0  %                   46                       3.2  %
Income from operations                                    394                      33.0  %                  592                      41.0  %
Interest expense, net                                     268                      22.4  %                  252                      17.5  %
Refinancing costs                                          24                       2.0  %                    3                       0.2  %
Other income                                              (28)                     (2.3) %                    -                         -  %
Income tax provision                                       25                       2.1  %                   14                       1.0  %
Income from continuing operations                         105                       8.8  %                  323                      22.4  %
Less: Net income attributable to noncontrolling
interests                                                  (1)                     (0.1) %                    -                         -  %
Income from continuing operations attributable
to TD Group                                               104                       8.7  %                  323                      22.4  %
Loss from discontinued operations, net of tax               -                         -  %                   (4)                     (0.3) %
Net income attributable to TD Group             $         104                       8.7  %       $          319                      22.1  %


                                                                            

Twenty-Six Week Periods Ended


                                                 April 3, 2021             % of Sales             March 28, 2020             % of Sales
Net sales                                       $       2,301                     100.0  %       $        2,908                     100.0  %
Cost of sales                                           1,169                      50.8  %                1,288                      44.3  %
Selling and administrative expenses                       358                      15.6  %                  381                      13.1  %
Amortization of intangible assets                          65                       2.8  %                   86                       3.0  %
Income from operations                                    709                      30.8  %                1,153                      39.6  %
Interest expense, net                                     535                      23.3  %                  501                      17.2  %
Refinancing costs                                          24                       1.0  %                   26                       0.9  %
Other income                                              (33)                     (1.4) %                   (3)                     (0.1) %
Income tax provision                                       28                       1.2  %                   73                       2.5  %
Income from continuing operations                         155                       6.7  %                  556                      19.1  %
Less: Net income attributable to noncontrolling
interests                                                  (1)                        -  %                   (1)                        -  %
Income from continuing operations attributable
to TD Group                                               154                       6.7  %                  555                      19.1  %
Income from discontinued operations, net of tax             -                         -  %                   68                       2.3  %
Net income attributable to TD Group             $         154                       6.7  %       $          623                      21.4  %




                                       30

--------------------------------------------------------------------------------
  Table of Contents
Changes in Results of Operations
Thirteen week period ended April 3, 2021 compared with the thirteen week period
ended March 28, 2020
Total Company
•Net Sales. Net organic sales and acquisition sales and the related dollar and
percentage changes for the thirteen week periods ended April 3, 2021 and
March 28, 2020 were as follows (amounts in millions):
                               Thirteen Week Periods Ended                              % Change
                            April 3, 2021             March 28, 2020      Change      Total  Sales
Organic sales       $        1,151                   $        1,443      $ (292)           (20.3) %
Acquisition sales               43                                -          43              3.0  %
                    $        1,194                   $        1,443      $ (249)           (17.3) %


The decrease in organic sales of $292 million for the thirteen week period ended
April 3, 2021, compared to the thirteen week period ended March 28, 2020, is
primarily related to decreases in commercial OEM sales ($170 million, a decrease
of 37.2%) and commercial aftermarket sales ($170 million, a decrease of 37.4%);
partially offset by an increase in defense sales ($48 million, an increase of
9.1%). The decreases in the commercial aftermarket and commercial OEM markets
are attributable to the adverse impact that the COVID-19 pandemic has had on the
customer demand for air travel worldwide. The increase in defense sales are
primarily driven by the OEM market.
Acquisition sales represent sales of acquired businesses for the period up to
one year subsequent to their respective acquisition date. The acquisition sales
in the table above for the thirteen week period ended April 3, 2021 are
primarily attributable to the acquisition of Cobham Aero Connectivity ("CAC").
•Cost of Sales and Gross Profit. Cost of sales decreased by $23 million, or
3.7%, to $602 million for the thirteen week period ended April 3, 2021 compared
to $625 million for the thirteen week period ended March 28, 2020. Cost of sales
and the related percentage of total sales for the thirteen week periods ended
April 3, 2021 and March 28, 2020 were as follows (amounts in millions):
                                                  Thirteen Week Periods 

Ended


                                              April 3, 2021          March 28, 2020          Change             % Change
Cost of sales - excluding costs below       $        585            $         649          $   (64)                  (9.9) %
% of total sales                                    49.0    %                45.0  %
COVID-19 pandemic restructuring costs                 15                        -               15                 NM
% of total sales                                     1.3    %                   -  %
Inventory acquisition accounting
adjustments                                            6                        -                6                 NM
% of total sales                                     0.5    %                   -  %
Acquisition integration costs                          2                        2                -                      -  %
% of total sales                                     0.2    %                 0.1  %
Non-cash stock compensation expense                    2                        1                1                  100.0  %
% of total sales                                     0.2    %                 0.1  %
Foreign currency losses (gains)                        1                      (13)              14                  107.7  %
% of total sales                                     0.1    %                (0.9) %
Loss contract amortization                            (9)                     (14)               5                   35.7  %
% of total sales                                    (0.8)   %                (1.0) %
Total cost of sales                         $        602            $         625          $   (23)                  (3.7) %
% of total sales                                    50.4    %                43.3  %
Gross profit                                $        592            $         818          $  (226)                 (27.6) %
Gross profit percentage                             49.6    %                56.7  %


The decrease in the dollar amount of cost of sales during the thirteen week
period ended April 3, 2021 was primarily due to lower sales volume from
decreased customer demand due to the COVID-19 pandemic and the other factors
summarized above, including those factors that partially offset the decrease in
cost of sales.
                                       31
--------------------------------------------------------------------------------
  Table of Contents
Gross profit as a percentage of sales decreased by 7.1 percentage points to
49.6% for the thirteen week period ended April 3, 2021 from 56.7% for the
thirteen week period ended March 28, 2020. The decrease in the gross profit
percentage is primarily driven by COVID-19 pandemic restructuring costs,
unfavorable movement in foreign currency rates (primarily the U.S. dollar
weakening against the British pound), inventory acquisition accounting
adjustments, lower loss contract amortization and sales mix, specifically, lower
commercial aftermarket sales as a percentage of total net sales. Also, fixed
overhead costs incurred were spread over a lower production volume during the
thirteen week period ended April 3, 2021 further contributing to an adverse
impact to gross profit.
•Selling and Administrative Expenses. Selling and administrative expenses
decreased by $18 million to $162 million, or 13.6% of sales, for the thirteen
week period ended April 3, 2021 from $180 million, or 12.5% of sales, for the
thirteen week period ended March 28, 2020. Selling and administrative expenses
and the related percentage of total sales for the thirteen week periods ended
April 3, 2021 and March 28, 2020 were as follows (amounts in millions):
                                                        Thirteen Week 

Periods Ended


                                                    April 3, 2021          March 28, 2020          Change              % Change
Selling and administrative expenses - excluding
costs below                                       $        132            $         162          $    (30)                 (18.5) %
% of total sales                                          11.1    %                11.2  %
Non-cash stock compensation expense                         19                       10                 9                   90.0  %
% of total sales                                           1.6    %                 0.7  %
Acquisition transaction-related expenses                     5                        -                 5                 NM
% of total sales                                           0.4    %                   -  %
Acquisition integration costs                                3                        7                (4)                 (57.1) %
% of total sales                                           0.3    %                 0.5  %
COVID-19 pandemic restructuring costs                        3                        1                 2                  200.0  %
% of total sales                                           0.3    %                 0.1  %
Total selling and administrative expenses         $        162            $         180          $    (18)                 (10.0) %
% of total sales                                          13.6    %                12.5  %


The decrease in selling and administrative expenses during the thirteen week
period ended April 3, 2021 is primarily due to the realization of the cost
mitigation measures that began to be enacted in the second half of fiscal 2020
in response to the COVID-19 pandemic, partially offset by the other factors
summarized above. The material cost mitigation measures enacted to date are
described in Note 1, "Description of the Business and Impact of COVID-19
Pandemic."
•Amortization of Intangible Assets. Amortization of intangible assets was $36
million for the thirteen week period ended April 3, 2021 compared to $46 million
for the thirteen week period ended March 28, 2020. The decrease in amortization
expense of $10 million was due to amortization expense on sales order backlog
recorded in fiscal 2020 in connection with the acquisition of Esterline
Technologies Corporation ("Esterline") that did not occur in fiscal 2021 as
sales order backlog related to the Esterline acquisition was fully amortized by
the end of fiscal 2020. This was partially offset by amortization expense of
intangible assets related to the CAC acquisition in the second quarter of fiscal
2021.
•Interest Expense-net. Interest expense-net includes interest on borrowings
outstanding, amortization of debt issuance costs, original issue discount and
premium, revolving credit facility fees and interest on finance leases; slightly
offset by interest income. Interest expense-net increased $16 million, or 6.3%,
to $268 million for the thirteen week period ended April 3, 2021 from $252
million for the comparable thirteen week period last year. The increase in
interest expense-net was primarily due to an increase in the weighted average
level of outstanding borrowings, which was approximately $20.4 billion for the
thirteen week period ended April 3, 2021 and approximately $18.5 billion for the
thirteen week period ended March 28, 2020. The increase in the weighted average
level of borrowings was primarily due to the activity in fiscal 2020 consisting
of the issuance of $1,100 million in 8.00% Senior Secured Notes due 2025 (the
"2025 Secured Notes"), $400 million in 6.25% Senior Secured Notes due 2026 (the
"2026 New Secured Notes") and $200 million drawn on the revolving credit
facility. The weighted average interest rate for cash interest payments on total
borrowings outstanding for the thirteen week period ended April 3, 2021 was
5.0%.
•Refinancing Costs. Refinancing costs of $24 million were recorded for the
thirteen week period ended April 3, 2021 compared to $3 million recorded for the
thirteen week period ended March 28, 2020. The refinancing costs for the
thirteen week period ended April 3, 2021 were primarily related to fees incurred
on the early redemption of the 2024 Notes. The refinancing costs for thirteen
week period ended March 28, 2020 were primarily related to fees incurred to
refinance the term loans in February 2020.

                                       32
--------------------------------------------------------------------------------
  Table of Contents
•Other Income. Other income was $28 million for the thirteen week period ended
April 3, 2021. There was no other income recorded for the thirteen week period
ended March 28, 2020. Other income for the thirteen week period ended April 3,
2021 is primarily driven by a $22 million gain on the settlement of the property
insurance portion of the claim for Leach International Europe's Niort, France
operating facility fire in August 2019. The gain represents the insurance
proceeds received in excess of the carrying value of the damaged fixed assets
and inventory. The remaining $6 million is primarily driven by non-service
related components of net periodic benefit costs on the Company's defined
benefit pension plans ($3 million), receipt of Canadian governmental subsidies
for the pandemic ($2 million) and a net gain on sale recorded on the completed
divestitures of certain businesses ($1 million).
•Income Taxes. Income tax expense as a percentage of income before income taxes
was approximately 19.6% for the thirteen week period ended April 3, 2021
compared to 4.2% for the thirteen week period ended March 28, 2020. The
Company's higher effective tax rate for the thirteen week period ended April 3,
2021, was primarily due to the increase in the Company's net interest deduction
limitation pursuant to IRC Section 163(j) partially offset by the discrete
impact of excess tax benefits associated with share-based payments.
•Income from Discontinued Operations. There were no discontinued operations for
the thirteen week period ended April 3, 2021. Discontinued operations for the
thirteen week period ended March 28, 2020 included an adjustment of $4 million
to the gain recognized on the sale of the Souriau-Sunbank Connection
Technologies business ("Souriau-Sunbank").
•Net Income Attributable to TD Group. Net income attributable to TD Group
decreased $215 million, or 67.4%, to $104 million for the thirteen week period
ended April 3, 2021 compared to net income attributable to TD Group of $319
million for the thirteen week period ended March 28, 2020, primarily due to the
adverse impact that the COVID-19 pandemic had on the Company's operations as
well as the other factors referenced above.
•Earnings per Share. Basic and diluted earnings per share was $1.79 for the
thirteen week period ended April 3, 2021 and $5.56 per share for the thirteen
week period ended March 28, 2020. Basic and diluted earnings per share from
continuing operations was $1.79 for the thirteen week period ended April 3,
2021. Basic and diluted earnings (loss) per share from continuing operations and
discontinued operations was $5.63 and $(0.07), respectively, for the thirteen
week period ended March 28, 2020.
Business Segments
•Segment Net Sales. Net sales by segment for the thirteen week periods ended
April 3, 2021 and March 28, 2020 were as follows (amounts in millions):
                                                             Thirteen Week Periods Ended
                              April 3, 2021             % of Sales             March 28, 2020             % of Sales              Change             % Change
Power & Control              $         641                      53.7  %       $          747                      51.8  %       $  (106)                  (14.2) %
Airframe                               513                      43.0  %                  655                      45.4  %          (142)                  (21.7) %
Non-aviation                            40                       3.3  %                   41                       2.8  %            (1)                   (2.4) %
                             $       1,194                     100.0  %       $        1,443                     100.0  %       $  (249)                  (17.3) %


Sales for the Power & Control segment decreased $106 million, a decrease of
14.2%, for the thirteen week period ended April 3, 2021 compared to the thirteen
week period ended March 28, 2020. The sales decrease resulted primarily from
decreases in commercial aftermarket sales ($74 million, a decrease of 33.4%) and
commercial OEM sales ($66 million, a decrease of 34.3%); partially offset by an
increase in defense sales ($34 million, an increase of 10.3%). The decreases in
commercial aftermarket and commercial OEM sales are attributable to the COVID-19
pandemic and its adverse impact on the commercial aerospace sector.
Sales for the Airframe segment decreased $142 million, a decrease of 21.7%, for
the thirteen week period ended April 3, 2021 compared to the thirteen week
period ended March 28, 2020. The sales decrease resulted primarily from a
decrease in organic sales of $184 million, a decrease of 28.1%; partially offset
by acquisition sales related to CAC of $42 million, an increase of 6.4%. The
organic sales decrease resulted primarily from decreases in commercial OEM sales
($107 million, a decrease of 44.2%) and commercial aftermarket sales ($95
million, a decrease of 43.4%); partially offset by an increase in defense sales
($18 million, an increase of 9.6%). The decreases in commercial aftermarket and
commercial OEM sales are attributable to the COVID-19 pandemic and its adverse
impact on the commercial aerospace sector.
Sales for the Non-aviation segment decreased $1 million, a decrease of 2.4%, for
the thirteen week period ended April 3, 2021 compared to the thirteen week
period ended March 28, 2020. The sales decrease resulted primarily from a
decrease in defense sales ($4 million, a decrease of 66.5%); partially offset by
an increase in other non-aerospace sales ($3 million, an increase of 9.6%).
                                       33
--------------------------------------------------------------------------------
  Table of Contents
•EBITDA As Defined. EBITDA As Defined by segment for the thirteen week periods
ended April 3, 2021 and March 28, 2020 were as follows (amounts in millions):
                                                                      Thirteen Week Periods Ended
                                                             % of  Segment                                         % of  Segment
                                    April 3, 2021                Sales                  March 28, 2020                 Sales                  Change             % Change
Power & Control                    $        309                         48.2  %       $           381                         51.0  %       $   (72)                  (18.9) %
Airframe                                    208                         40.5  %                   296                         45.2  %           (88)                  (29.7) %
Non-aviation                                 16                         40.0  %                    14                         34.1  %             2                    14.3  %
                                   $        533                         44.6  %       $           691                         47.9  %       $  (158)                  (22.9) %


EBITDA As Defined for the Power & Control segment decreased approximately $72
million, a decrease of 18.9%, resulting from lower sales volume in the
commercial aftermarket and commercial OEM markets due to the COVID-19 pandemic
and its adverse impact on the commercial aerospace sector.
Organic EBITDA as Defined for the Airframe segment decreased approximately $95
million, a decrease of 32.1%, primarily as a result of lower sales volume in the
commercial aftermarket and commercial OEM markets due to the COVID-19 pandemic
and its adverse impact on the commercial aerospace sector. EBITDA as Defined for
the Airframe segment from the acquisition of CAC in fiscal year 2021 was $7
million.
EBITDA As Defined for the Non-aviation segment increased approximately $2
million, an increase of 14.3%, resulting from a favorable sales mix specifically
from other non-aerospace sales.
Twenty-six week period ended April 3, 2021 compared with the twenty-six week
period ended March 28, 2020
Total Company
•Net Sales. Net organic sales and acquisition sales and the related dollar and
percentage changes for the twenty-six week periods ended April 3, 2021 and
March 28, 2020 were as follows (amounts in millions):
                                                    Twenty-Six Week Periods Ended                                      % Change
                                                April 3, 2021           March 28, 2020           Change              Total  Sales
Organic sales                                $          2,258          $        2,908          $   (650)                      (22.4) %

Acquisition sales                                          43                       -                43                         1.5  %
                                             $          2,301          $        2,908          $   (607)                      (20.9) %


The decrease in organic sales for the twenty-six week period ended April 3, 2021
compared to the twenty-six week period ended March 28, 2020, is primarily
related to a decrease in commercial aftermarket sales ($389 million, a decrease
of 41.9%) and commercial OEM sales ($313 million, a decrease of 35.0%);
partially offset by an increase in defense sales ($52 million, an increase of
4.8%). The decreases in the commercial aftermarket and commercial OEM markets
are attributable to the adverse impact that the COVID-19 pandemic has had on the
customer demand for air travel worldwide. The increase in defense sales is
primarily driven by the OEM market.
Acquisition sales represent sales of acquired businesses for the period up to
one year subsequent to their respective acquisition dates. The acquisition sales
displayed in the table above for the twenty-six week period ended April 3, 2021
are primarily attributable to the acquisition of CAC.
                                       34
--------------------------------------------------------------------------------
  Table of Contents
•Cost of Sales and Gross Profit. Cost of sales decreased by $119 million, or
9.2%, to $1,169 million for the twenty-six week period ended April 3, 2021
compared to $1,288 million for the twenty-six week period ended March 28, 2020.
Cost of sales and the related percentage of total sales for the twenty-six week
periods ended April 3, 2021 and March 28, 2020 were as follows (amounts in
millions):
                                                   Twenty-Six Week Periods Ended
                                                April 3, 2021          March 28, 2020          Change              % Change
Cost of sales - excluding costs below         $       1,130           $       1,305          $   (175)                  (13.4) %
% of total sales                                       49.1   %                44.9  %
COVID-19 pandemic restructuring costs                    28                       -                28                 NM
% of total sales                                        1.2   %                   -  %
Foreign currency losses                                  23                       1                22                 NM
% of total sales                                        1.0   %                   -  %
Non-cash stock compensation expense                       7                       4                 3                    75.0  %
% of total sales                                        0.3   %                 0.1  %
Inventory acquisition accounting adjustments              6                       -                 6                 NM
% of total sales                                        0.3   %                   -  %
Acquisition integration costs                             2                       3                (1)                  (33.3) %
% of total sales                                        0.1   %                 0.1  %
Loss contract amortization                              (27)                    (25)               (2)                   (8.0) %
% of total sales                                       (1.2)  %                (0.9) %
Total cost of sales                           $       1,169           $       1,288          $   (119)                   (9.2) %
% of total sales                                       50.8   %                44.3  %
Gross profit                                  $       1,132           $       1,620          $   (488)                  (30.1) %
Gross profit percentage                                49.2   %                55.7  %


The decrease in the dollar amount of cost of sales during the twenty-six week
period ended April 3, 2021 was primarily due to lower sales volume from
decreased customer demand due to the COVID-19 pandemic and the other factors
summarized above, including those factors that partially offset the decrease in
cost of sales.
Gross profit as a percentage of sales decreased by 6.5 percentage points to
49.2% for the twenty-six week period ended April 3, 2021 from 55.7% for the
twenty-six week period ended March 28, 2020. The dollar amount of gross profit
decreased by $488 million, or 30.1%, for the twenty-six week period ended
April 3, 2021 compared to the twenty-six week period in the prior year. The
decrease in the gross profit percentage is primarily driven by COVID-19 pandemic
restructuring costs, unfavorable movement in foreign currency rates (primarily
the U.S. dollar weakening against the British pound and Euro) and sales mix,
specifically, lower commercial aftermarket sales as a percentage of total net
sales. Also, fixed overhead costs incurred were spread over a lower production
volume during the twenty-six week period April 3, 2021 further contributing to
an adverse impact to gross profit.
                                       35
--------------------------------------------------------------------------------
  Table of Contents
•Selling and Administrative Expenses. Selling and administrative expenses
decreased by $23 million to $358 million, or 15.6% of sales, for the twenty-six
week period ended April 3, 2021 from $381 million, or13.1% of sales, for the
twenty-six week period ended March 28, 2020. Selling and administrative expenses
and the related percentage of total sales for the twenty-six week periods ended
April 3, 2021 and March 28, 2020 were as follows (amounts in millions):
                                                        Twenty-Six Week 

Periods Ended


                                                    April 3, 2021           March 28, 2020           Change              % Change
Selling and administrative expenses - excluding
costs below                                       $         274            $         334          $     (60)                  (18.0) %
% of total sales                                           11.9    %                11.5  %
Non-cash stock compensation expense                          63                       33                 30                    90.9  %
% of total sales                                            2.7    %                 1.1  %
COVID-19 pandemic restructuring costs                        10                        1                  9                 NM
% of total sales                                            0.4    %                   -  %
Acquisition transaction-related expenses                      6                        1                  5                 NM
% of total sales                                            0.3    %                   -  %
Acquisition integration costs                                 5                       12                 (7)                  (58.3) %
% of total sales                                            0.2    %                 0.4  %
Total selling and administrative expenses         $         358            $         381          $     (23)                   (6.0) %
% of total sales                                           15.6    %                13.1  %


The decrease in the dollar amount of selling and administrative expenses during
the twenty-six week period ended April 3, 2021 is primarily due to the
realization of the cost mitigation measures that began to be enacted in the
second half of fiscal 2020 in response to the COVID-19 pandemic, partially
offset by the other factors summarized above. The material cost mitigation
measures enacted to date are described in Note 1, "Description of the Business
and Impact of COVID-19 Pandemic." The increase in non-cash stock compensation
expense is attributable to the new stock option grants awarded in the first
quarter of fiscal 2021 and the impact on the Black-Scholes fair value of the
fiscal 2020 grants in connection with the change in vesting terms approved by
the Compensation Committee of the Board of Directors in the first quarter of
fiscal 2021.
•Amortization of Intangible Assets. Amortization of intangible assets was $65
million for the twenty-six week period ended April 3, 2021 compared to $86
million for the twenty-six week period ended March 28, 2020. The decrease in
amortization expense of $21 million was due to the amortization expense on sales
order backlog recorded in fiscal 2020 in connection with the acquisition of
Esterline that did not occur in fiscal 2021 as sales order backlog related to
the Esterline acquisition was fully amortized by the end of fiscal 2020. This
was partially offset by amortization expense of intangible assets related to the
CAC acquisition in the second quarter of fiscal 2021.
•Refinancing Costs. Refinancing costs of $24 million were recorded for the
twenty-six week period ended April 3, 2021 compared to $26 million recorded for
the twenty-six week period ended March 28, 2020. The refinancing costs primarily
related to fees incurred on the early redemption of the 2024 Notes that occurred
in the second quarter of fiscal 2021 and on the early redemption of the 6.00%
Senior Subordinated Notes due 2022 (the "2022 Notes") that occurred in the first
quarter of fiscal 2020.
•Other Income. Other income of $33 million was recorded for the twenty-six week
period ended April 3, 2021 compared to $3 million recorded for the twenty-six
week period ended March 28, 2020. Other income for the twenty-six week period
April 3, 2021 was primarily driven by a $22 million gain on the settlement of
the property insurance portion of the claim for Leach International Europe's
Niort, France operating facility fire in August 2019. The gain represents the
insurance proceeds received in excess of the carrying value of the damaged fixed
assets and inventory. The remaining $11 million is primarily driven by
non-service related components of net periodic benefit costs on the Company's
defined benefit pension plans ($6 million), receipt of payment of a Canadian
governmental subsidy ($4 million) and a net gain on sale recorded on the
completed divestitures of certain businesses ($1 million). Other income for the
twenty-six week period ended March 28, 2020 is primarily related to non-service
related components of net periodic benefit costs on the Company's defined
benefit pension plans.
                                       36
--------------------------------------------------------------------------------
  Table of Contents
•Interest Expense-net. Interest expense-net includes interest on borrowings
outstanding, amortization of debt issuance costs, original issue discount and
premium, revolving credit facility fees and interest on finance leases; slightly
offset by interest income. Interest expense-net increased $34 million, or 6.8%,
to $535 million for the twenty-six week period ended April 3, 2021 from $501
million for the comparable twenty-six week period last year. The increase in
interest expense-net was primarily due to an increase in the weighted average
level of outstanding borrowings, which was approximately $20.2 billion for the
twenty-six week period ended April 3, 2021 and approximately $18.2 billion for
the twenty-six week period ended March 28, 2020. The increase in the weighted
average level of borrowings was primarily due to the activity in fiscal 2020
consisting of the issuance of $1,100 million in 2025 Secured Notes, $400 million
in 2026 New Secured Notes and $200 million drawn on the revolving credit
facility. The weighted average interest rate for cash interest payments on total
borrowings outstanding for the thirteen week period ended April 3, 2021 was
5.1%.
•Income Taxes. Income tax expense as a percentage of income before income taxes
was approximately 15.5% for the twenty-six week period ended April 3, 2021
compared to 11.6% for the twenty-six week period ended March 28, 2020. The
Company's higher effective tax rate for the twenty-six week period ended
April 3, 2021 was primarily due to the increase in the Company's net interest
deduction limitation pursuant to IRC Section 163(j) partially offset by the
discrete impact of excess tax benefits associated with share-based payments.
•Income from Discontinued Operations. There were no discontinued operations for
the twenty-six week period ended April 3, 2021. Discontinued operations for the
twenty-six week period ended March 28, 2020 include the results of the
operations of the Souriau-Sunbank. On December 20, 2019, TransDigm completed the
divestiture of Souriau-Sunbank to Eaton Corporation plc ("Eaton") for
approximately $920 million. Souriau-Sunbank was acquired by TransDigm as part of
its acquisition of Esterline in March 2019. The income from discontinued
operations for the twenty-six week period ended March 28, 2020 is $68 million
and includes $8 million from Souriau-Sunbank's operations and a gain on the sale
of Souriau-Sunbank, net of tax, of $60 million.
•Net Income Attributable to TD Group. Net income attributable to TD Group
decreased $469 million, or 75.3%, to $154 million for the twenty-six week period
ended April 3, 2021 compared to net income attributable to TD Group of $623
million for the twenty-six week period ended March 28, 2020, primarily as a
result of the factors referenced above.
•Earnings per Share. Basic and diluted earnings per share was $1.40 for the
twenty-six week period ended April 3, 2021 and $7.63 per share for the
twenty-six week period ended March 28, 2020. There was no impact on earnings per
share from discontinued operations for the twenty-six week period ended April 3,
2021. Basic and diluted earnings per share from continuing operations and
discontinued operations were $6.45 and $1.18, respectively, for the twenty-six
week period ended March 28, 2020.
Business Segments
•Segment Net Sales. Net sales by segment for the twenty-six week period ended
April 3, 2021 and March 28, 2020 were as follows (amounts in millions):
                                                            Twenty-Six Week Periods Ended
                              April 3, 2021             % of Sales             March 28, 2020             % of Sales              Change              % Change
Power & Control              $       1,242                      54.0  %       $        1,499                      51.5  %       $   (257)                  (17.1) %
Airframe                               977                      42.4  %                1,329                      45.7  %           (352)                  (26.5) %
Non-aviation                            82                       3.6  %                   80                       2.8  %              2                     2.5  %
                             $       2,301                     100.0  %       $        2,908                     100.0  %       $   (607)                  (20.9) %


Sales for the Power & Control segment decreased $257 million, a decrease of
17.1%, for the twenty-six week period ended April 3, 2021. The sales decrease
resulted primarily from a decrease in commercial aftermarket sales ($161
million, a decrease of 36.5%) and a decrease in commercial OEM sales ($125
million, a decrease of 33.0%); partially offset by an increase in defense sales
($29 million, an increase of 4.4%). The decreases in commercial aftermarket and
commercial OEM sales are attributable to the COVID-19 pandemic and its adverse
impact on the commercial aerospace sector.
Sales for the Airframe segment decreased $352 million, a decrease of 26.5%, for
the twenty-six week period ended April 3, 2021. The sales decrease resulted
primarily from a decrease in organic sales of $394 million, a decrease of 29.6%;
partially offset by acquisition sales related to CAC of $42 million, an increase
of 3.2%. The organic sales decrease resulted primarily from decreases in
commercial aftermarket sales ($228 million, a decrease of 49.1%) and commercial
aftermarket sales ($195 million, a decrease of 41.3%); partially offset by an
increase in defense sales ($29 million, an increase of 7.5%). The decreases in
commercial aftermarket and commercial OEM sales are attributable to the COVID-19
pandemic and its adverse impact on the commercial aerospace sector.
                                       37
--------------------------------------------------------------------------------
  Table of Contents
Sales for the Non-aviation increased by $2 million, an increase of 2.5%, for the
twenty-six week period ended April 3, 2021 compared to the twenty-six week
period ended March 28, 2020. The sales increase resulted primarily from an
increase in other non-aerospace sales ($6 million, an increase of 10.7%);
partially offset by a decrease in defense sales ($4 million, a decrease of
36.1%).
•EBITDA As Defined. EBITDA As Defined by segment for the twenty-six week periods
ended April 3, 2021 and March 28, 2020 were as follows (amounts in millions):
                                                                     

Twenty-Six Week Periods Ended


                                                              % of  Segment                                        % of  Segment
                                    April 3, 2021                 Sales                 March 28, 2020                 Sales                  Change              % Change
Power & Control                    $         613                         49.4  %       $          766                         51.1  %       $   (153)                  (20.0) %
Airframe                                     385                         39.4  %                  602                         45.3  %           (217)                  (36.0) %
Non-aviation                                  31                         37.8  %                   26                         32.5  %              5                    19.2  %
                                   $       1,029                         44.7  %       $        1,394                         47.9  %       $   (365)                  (26.2) %


EBITDA As Defined for the Power & Control segment decreased approximately $153
million, a decrease of 20.0%, resulting from lower sales volume in the
commercial aftermarket and commercial OEM market due to the COVID-19 pandemic
and its adverse impact on the commercial aerospace sector.
Organic EBITDA as Defined for the Airframe segment decreased approximately $224
million, a decrease of 37.2%, primarily as a result of lower sales volume in the
commercial aftermarket and commercial OEM markets due to the COVID-19 pandemic
and its adverse impact on the commercial aerospace sector. EBITDA as Defined for
the Airframe segment from the acquisition of CAC in fiscal year 2021 was $7
million.
EBITDA As Defined for the Non-aviation segment increased approximately $5
million, an increase of 19.2%, resulting from a favorable sales mix specifically
from other non-aerospace sales.
Backlog
As of April 3, 2021, the Company estimated its sales order backlog at $3,314
million compared to $3,579 million as of March 28, 2020. The decrease in backlog
is attributable to the adverse impact that the COVID-19 pandemic has had on
customer demand, particularly our commercial customers, domestically and
internationally. The uncertainty of the duration of the pandemic and its impact
on the commercial aerospace industry is expected to continue to restrain sales
order backlog growth in the commercial OEM and commercial aftermarket channels
throughout fiscal 2021.
The majority of the purchase orders outstanding as of April 3, 2021 are
scheduled for delivery within the next twelve months. Purchase orders may be
subject to cancellation or deferral by the customer prior to shipment. The level
of unfilled purchase orders at any given date during the year will be materially
affected by the timing of the Company's receipt of purchase orders and the speed
with which those orders are filled. Accordingly, the Company's backlog as of
April 3, 2021 may not necessarily represent the actual amount of shipments or
sales for any future period.
Foreign Operations
Although we manufacture a significant portion of our products in the United
States, we manufacture certain products in Europe, Asia, Canada, Mexico and
other countries globally. We sell our products in the United States as well as
in foreign countries. Although the majority of sales of our products are made to
customers (including distributors) located in the United States, our products
are ultimately sold to and used by customers, including airlines and other end
users of aircraft, throughout the world.
Sales to foreign customers are subject to numerous additional risks, including
the COVID-19 pandemic, foreign currency fluctuations, the impact of foreign
government regulations, political uncertainties and differences in business
practices. There can be no assurance that foreign governments will not adopt
regulations or take other action that would have a direct or indirect adverse
impact on the business or market opportunities of the Company within such
governments' countries. Furthermore, there can be no assurance that the
political, cultural and economic climate outside the United States will be
favorable to our operations and growth strategy.
Liquidity and Capital Resources
We have historically maintained a capital structure comprising a mix of equity
and debt financing. We vary our leverage both to optimize our equity return and
to pursue acquisitions. We expect to meet our current debt obligations as they
come due through internally generated funds from current levels of operations
and/or through refinancing in the debt markets prior to the maturity dates of
our debt.
                                       38
--------------------------------------------------------------------------------
  Table of Contents
If the Company has excess cash, it generally prioritizes allocating the excess
cash in the following manner: (1) capital spending at existing businesses, (2)
acquisitions of businesses, (3) payment of a special dividend and/or repurchases
of our common stock and (4) prepayment of indebtedness or repurchase of debt.
Whether the Company undertakes common stock repurchases or other aforementioned
activities will depend on prevailing market conditions, the Company's liquidity
requirements, contractual restrictions and other factors. The amounts involved
may be material. In addition, the Company may issue additional debt if
prevailing market conditions are favorable to doing so.
The Company's ability to make scheduled interest payments on, or to refinance,
the Company's indebtedness, or to fund non-acquisition related capital
expenditures and research and development efforts, will depend on the Company's
ability to generate cash in the future. This is subject to general economic,
financial, competitive, legislative, regulatory and other factors that are
beyond its control, including the ongoing COVID-19 pandemic.
The COVID-19 pandemic has caused a significant adverse impact on our sales, net
income and EBITDA as Defined during the twenty-six week period ended April 3,
2021 and is expected to continue to do so for at least the remainder of fiscal
2021. This is under the assumption that the COVID-19 pandemic will continue to
adversely impact customer demand for all market channels with commercial OEM and
commercial aftermarket being the most adversely impacted due to the pandemic's
impact on air travel demand worldwide. The defense market channel is also
impacted to a lesser extent due to certain supply chain disruptions as well as
the "stay at home" orders, quarantines, etc. impacting the government
procurement workforce which has slowed production and/or orders. Also,
government funding reprioritization such as shifting funds to efforts to combat
the impact of the pandemic provides for uncertainty.
Although commercial air travel demand has shown slight signs of recovery in
recent months, the recovery is expected to continue to be slow and uneven
depending on factors such as trends in the number of COVID-19 infections (e.g.,
impact of new variants of COVID-19 surfacing), the rollout and effectiveness of
the vaccine, and the eventual easing of quarantines and travel restrictions,
among other factors. The exact timing and pace of the recovery is indeterminable
as certain markets have reopened, some of which have since experienced a
resurgence of COVID-19 cases, and in recent months new variants of COVID-19 have
been identified, resulting in additional restrictions put in place by certain
governments around the world. The magnitude of the impact of COVID-19 remains
unpredictable and we, therefore, continue to anticipate potential supply chain
disruptions, employee absenteeism and short-term suspensions of manufacturing
facilities, and additional health and safety costs related to the COVID-19
pandemic that could unfavorably impact our business. Longer term, because the
duration of the pandemic is unclear, it is difficult to forecast a precise
impact on the Company's future results.
The Company is actively managing the business to maintain cash flow, including
the cost mitigation efforts described in Note 1, "Description of the Business
and Impact of COVID-19 Pandemic," in the notes to the condensed consolidated
financial statements included herein in response to the COVID-19 pandemic and is
continuing to focus on the application of its three core value-driven operating
strategies (obtaining profitable new business, continually improving its cost
structure and providing highly engineered value-added products to customers).
In March 2020, the Company drew $200 million on its revolving credit facility to
increase the Company's liquidity as a precautionary response to macroeconomic
conditions caused by the COVID-19 pandemic. The $200 million drawn was
subsequently repaid and redrawn within the first quarter of fiscal 2021. Also,
in further action to increase the Company's liquidity, the Company executed two
notes offerings in April 2020 in which the proceeds received were for general
Corporate purposes. On April 8, 2020, the Company entered into a purchase
agreement in connection with a private offering of $1,100 million of the 2025
Secured Notes at an issue price of 100% of the principal amount. On April 17,
2020, the Company entered into a purchase agreement in connection with a private
offering of $400 million of the 2026 New Secured Notes at an issue price of 101%
of the principal amount.
As of April 3, 2021, the Company has significant cash liquidity as illustrated
in the table presented below (in millions):
                                                          As of April 3, 2021
         Cash and cash equivalents                       $              4,072
         Availability on revolving credit facility                        520
         Cash liquidity                                  $              4,592



                                       39

--------------------------------------------------------------------------------
  Table of Contents
Due to favorable market conditions in the high yield bond market, on January 14,
2021, the Company entered into a purchase agreement in connection with a private
offering of $1,200 million of 4.625% Senior Subordinated Notes due 2029 (the
"4.625% 2029 Notes") at an issue price of 100% of the principal amount. The
4.625% 2029 Notes were issued pursuant to an indenture, dated January 20, 2021.
The Company used the net proceeds from the offering of the 4.625% 2029 Notes to
redeem all of its outstanding 6.50% Senior Subordinated Notes due 2024 (the
"2024 Notes"), effectively resulting in a reduced interest rate and an extended
maturity date of $1,200 million in senior subordinated notes. In addition, on
April 12, 2021, the Company entered into a purchase agreement in connection with
a private offering of $750 million of 4.875% Senior Subordinated Notes due 2029
(the "4.875% 2029 Notes") at an issue price of 100% of the principal amount. The
4.875% 2029 Notes were issued pursuant to an indenture, dated April 21, 2021.
The Company expects to use the net proceeds from the offering of the 4.875% 2029
Notes to redeem all of its outstanding 6.50% Senior Subordinated Notes due 2025
(the "2025 Notes"), effectively resulting in a reduced interest rate and an
extended maturity date of $750 million in senior subordinated notes.
We believe our significant cash liquidity will allow us to meet our anticipated
funding requirements. We expect to meet our short-term cash liquidity
requirements (including interest obligations and capital expenditures) through
net cash from operating activities, cash on hand and, if needed, additional
draws on the revolving credit facility. Long-term cash liquidity requirements
consist primarily of obligations under our long-term debt agreements. There will
be no maturity on any tranche of term loans or notes until August 2024.
In connection with the continued application of our three core value-driven
operating strategies (obtaining profitable new business, continually improving
our cost structure and providing highly engineered value-added products to
customers), we expect our efforts will continue to generate strong margins and
provide sufficient cash provided by operating activities to meet our interest
obligations and liquidity needs. We believe our cash provided by operating
activities and available borrowing capacity will enable us to make strategic
business acquisitions (such as the CAC acquisition completed in the second
quarter of fiscal 2021 for an enterprise value of $965 million using existing
cash on hand), pay dividends to our shareholders and make opportunistic
investments in our own stock, subject to any restrictions in our existing credit
agreement and market conditions in consideration of the ongoing COVID-19
pandemic.
In the future, the Company may increase its borrowings in connection with
acquisitions, if cash flow from operating activities becomes insufficient to
fund current operations or for other short-term cash needs or for stock
repurchases or dividends. Our future leverage will also be impacted by the then
current conditions of the credit markets.
Operating Activities. The Company generated $372 million of net cash from
operating activities during the twenty-six week period ended April 3, 2021
compared to $594 million during the twenty-six week period ended March 28, 2020.
The change in accounts receivable during the twenty-six week period ended
April 3, 2021 was a source of cash of $39 million compared to a source of cash
of $74 million during the twenty-six week period ended March 28, 2020. The
decrease in the source of cash of $35 million is primarily attributable to the
decrease in accounts receivable from lower sales due to the COVID-19 pandemic.
The Company continues to actively manage its accounts receivable, the related
agings and collection efforts in response to the COVID-19 pandemic.
The change in inventories during the twenty-six week period ended April 3, 2021
was a source of cash of $32 million compared to a use of cash of $97 million
during the twenty-six week period ended March 28, 2020. The increase in the
source of cash is primarily driven by decreased purchasing from reduced demand
and actively managing inventory levels as a result of the COVID-19 pandemic.
The change in accounts payable during the twenty-six week period ended April 3,
2021 was a use of cash of $7 million compared to a use of cash of $12 million
during the twenty-six week period ended March 28, 2020.
Investing Activities. Net cash used in investing activities was $952 million
during the twenty-six week period ended April 3, 2021, consisting primarily of
$951 million from the acquisition of CAC in the second quarter of fiscal 2021
and capital expenditures of $60 million. This was partially offset by proceeds
of $35 million from the completion of the divestitures of certain businesses,
and $24 million of insurance proceeds received from the Leach International
Europe fire property claim.
Net cash provided by investing activities was $854 million during the twenty-six
week period ended March 28, 2020, consisting of proceeds of $904 million from
the completion of the divestiture of Souriau-Sunbank. This was partially offset
by capital expenditures of $50 million.
Financing Activities. Net cash used in financing activities during the
twenty-six week period ended April 3, 2021 was $73 million. The use of cash was
primarily attributable to the redemption of the 2024 Notes for $1,220 million,
dividend equivalent payments of $73 million and repayment on term loans of $38
million. This was partially offset by $1,189 million in net proceeds from the
completion of the 4.625% 2029 Notes offering and $69 million in proceeds from
stock option exercises.
                                       40
--------------------------------------------------------------------------------
  Table of Contents
Net cash used in financing activities during the twenty-six week period ended
March 28, 2020 was $248 million. The use of cash was primarily attributable to
dividend equivalent payments of $1,928 million, the redemption of the 2022 Notes
for $1,168 million, the purchase of treasury stock of $19 million and repayments
on term loans of $19 million. The use of cash was partially offset by $2,625
million in net proceeds from the completion of the 5.50% Senior Subordinated
Notes due 2027 (the "5.50% 2027 Notes") offering, $200 million in proceeds from
the revolving credit facility and $69 million in proceeds from stock option
exercises.
Contractual Obligations
We have future obligations under various contracts relating to debt and interest
payments, finance and operating leases, pension and post-retirement benefit
plans and purchase obligations. There were no material changes during the
twenty-six week period ended April 3, 2021 to these obligations as reported in
our Annual Report on Form 10-K for the fiscal year ended September 30, 2020
other than the debt financing transactions that have occurred in fiscal 2021
(refer to Note 9, "Debt" in the notes to the condensed consolidated financial
statements included herein) effectively resulting in a reduced interest rate and
an extended maturity date for $1,950 million in senior subordinated notes.
Description of Senior Secured Term Loans and Indentures
Senior Secured Term Loans Facility
TransDigm has $7,411 million in fully drawn term loans (the "Term Loans
Facility") and a $760 million revolving credit facility. The Term Loans Facility
consists of three tranches of term loans as follows (aggregate principal amount
disclosed is as of April 3, 2021):
  Term Loans Facility        Aggregate Principal        Maturity Date         Interest Rate
       Tranche E               $2,188 million            May 30, 2025         LIBOR + 2.25%
       Tranche F               $3,471 million          December 9, 2025       LIBOR + 2.25%
       Tranche G               $1,752 million          August 22, 2024        LIBOR + 2.25%


The Term Loans Facility requires quarterly aggregate principal payments of $18.8
million. The revolving commitments consist of two tranches which include up to
$151.5 million of multicurrency revolving commitments. At April 3, 2021, the
Company had $39.7 million in letters of credit outstanding, $200.0 million drawn
and outstanding and $520.3 million in borrowings available under the revolving
commitments.
The interest rates per annum applicable to the loans under the Credit Agreement
are, at TransDigm's option, equal to either an alternate base rate or an
adjusted LIBOR for one, two, three or six-month (or to the extent agreed to by
each relevant lender, nine or twelve-month) interest periods chosen by
TransDigm, in each case plus an applicable margin percentage. The adjusted LIBOR
related to tranche E, tranche F and tranche G term loans are not subject to a
floor. For the twenty-six week period ended April 3, 2021, the applicable
interest rate was approximately 2.4% on the existing term loans. Interest rate
swaps and caps used to hedge and offset, respectively, the variable interest
rates on the credit facility are described in Note 12, "Derivatives and Hedging
Activities," in the notes to the condensed consolidated financial statements
included herein.
Recent Amendments to the Credit Agreement
On February 6, 2020, the Company entered into Amendment No. 7 and Refinancing
Facility Agreement (herein, "Amendment No. 7"). Under the terms of Amendment No.
7, the Company, among other things, (i) incurred new tranche E term loans in an
aggregate principal amount equal to approximately $2,216 million, new tranche F
term loans in an aggregate principal amount equal to approximately $3,515
million and new tranche G term loans, (collectively, the "New Term Loans") in an
aggregate principal amount equal to approximately $1,774 million, (ii) repaid in
full all of the existing tranche E term loans, tranche F term loans and tranche
G term loans outstanding under the Credit Agreement immediately prior to
Amendment No. 7 and (iii) extended the maturity date of the tranche F term loans
to December 9, 2025, (iv) modified the definition of consolidated EBITDA in the
Credit Agreement to add back certain cost savings and non-recurring cost and
expenses and (v) modified certain negative covenants to provide additional
flexibility to enable TransDigm to incur additional debt and make additional
investments and asset sales.
The New Term Loans were fully drawn on February 6, 2020. The LIBOR per annum
applicable to the New Term Loans is 2.25%, a decrease from the previous rate of
2.50%. The other terms and conditions that apply to the New Term Loans are
substantially the same as the terms and conditions that applied to the term
loans immediately prior to Amendment No. 7.
                                       41
--------------------------------------------------------------------------------
  Table of Contents
Indentures
The following table represents the notes outstanding as of April 3, 2021:
    Description           Aggregate Principal         Maturity Date         Interest Rate
   2025 Notes (1)            $750 million             May 15, 2025              6.50%
 2025 Secured Notes         $1,100 million          December 15, 2025           8.00%
 2026 Secured Notes         $4,400 million           March 15, 2026             6.25%
 6.875% 2026 Notes           $500 million             May 15, 2026             6.875%
 6.375% 2026 Notes           $950 million             June 15, 2026            6.375%
  7.50% 2027 Notes           $550 million            March 15, 2027             7.50%
  5.50% 2027 Notes          $2,650 million          November 15, 2027           5.50%
 4.625% 2029 Notes          $1,200 million            July 15, 2029            4.625%




(1)On April 12, 2021, the Company entered into a purchase agreement in
connection with a private offering of the 4.875% 2029 Notes at an issue price of
100% of the principal amount. The Company expects to use the net proceeds from
the offering of the 4.875% 2029 Notes to redeem all of its outstanding 2025
Notes. Refer to Note 9, "Debt," in the notes to the condensed consolidated
financial statements included herein for additional details.
The 6.375% 2026 Notes, the 7.50% 2027 Notes, the 5.50% 2027 Notes and the 4.625%
2029 Notes (collectively, the "TransDigm Inc. Notes") were issued at a price of
100% of the principal amount. The initial $450 million offering of the 2025
Notes (also considered to be part of the "TransDigm Inc. Notes") were issued at
a price of 100% of the principal amount and the subsequent $300 million offering
of 2025 Notes in the second quarter of fiscal 2017 were issued at a price of
101.5% of the principal amount, resulting in gross proceeds of $304.5 million.
The 6.875% 2026 Notes (the "TransDigm UK Notes" and together with the TransDigm
Inc. Notes, the "Notes," are further described below) offered in May 2018 were
issued at a price of 99.24% of the principal amount, resulting in gross proceeds
of $496.2 million. The 2025 Secured Notes (the "Secured Notes") were issued at a
price 100% of the principal amount. The initial $3,800 million offering of the
2026 Secured Notes (the "Secured Notes") were issued at a price of 100% of their
principal amount and the subsequent $200 million and $400 million offerings of
the 2026 Secured Notes in the second quarter of fiscal 2019 and the third
quarter of fiscal 2020, respectively, were issued at a price of 101% of their
principal amount, resulting in gross proceeds of $4,410.5 million.
The Notes do not require principal payments prior to their maturity. Interest
under the Notes is payable semi-annually. The Notes represent our unsecured
obligations ranking subordinate to our senior debt, as defined in the applicable
indentures. The Notes contain many of the restrictive covenants included in the
Credit Agreement. TransDigm is in compliance with all of the covenants contained
in the Notes.
The Notes are subordinated to all of our existing and future senior debt, rank
equally with all of our existing and future senior subordinated debt and rank
senior to all of our future debt that is expressly subordinated to the Notes.
The TransDigm, Inc. Notes are fully and unconditionally guaranteed on a senior
subordinated unsecured basis by TD Group and TransDigm, Inc.'s Domestic
Restricted Subsidiaries. The TransDigm UK Notes are guaranteed on a senior
subordinated basis by TransDigm, Inc., TD Group and TransDigm, Inc.'s Domestic
Restricted Subsidiaries. The guarantees of the Notes are subordinated to all of
the guarantors' existing and future senior debt, rank equally with all of their
existing and future senior subordinated debt and rank senior to all of their
future debt that is expressly subordinated to the guarantees of the Notes. The
Notes are structurally subordinated to all of the liabilities of TD Group's
non-guarantor subsidiaries.
The Secured Notes are senior secured obligations of TransDigm and rank equally
in right of payment with all of TransDigm's existing and future senior secured
debt, including indebtedness under TransDigm's existing senior secured credit
facilities, and are senior in right of payment to all of TransDigm's existing
and future senior subordinated debt, including the Notes, TransDigm's other
outstanding senior subordinated notes and TransDigm's guarantees in respect of
TransDigm UK's outstanding senior subordinated notes. The Secured Notes are
guaranteed on a senior secured basis by TD Group, TransDigm UK and TransDigm's
wholly-owned U.S. subsidiaries named in the Secured Notes Indenture. The
guarantees of the Secured Notes rank equally in right of payment with all of the
guarantors' existing and future senior secured debt and are senior in right of
payment to all of their existing and future senior subordinated debt. The
Secured Notes are structurally subordinated to all of the liabilities of
TransDigm's non-guarantor subsidiaries. The Secured Notes contain many of the
restrictive covenants included in the Credit Agreement. TransDigm is in
compliance with all of the covenants contained in the Secured Notes.


                                       42
--------------------------------------------------------------------------------
  Table of Contents
Guarantor Information
Separate financial statements of TransDigm, Inc. are not presented because the
Secured Notes are fully and unconditionally guaranteed on a senior secured basis
by TD Group, TransDigm UK and all of TransDigm, Inc.'s Domestic Restricted
Subsidiaries. TD Group has no significant operations or assets separate from its
investment in TransDigm, Inc.
Separate financial statements of TransDigm, Inc. are not presented because the
TransDigm, Inc. Notes are fully and unconditionally guaranteed on a senior
subordinated basis by TD Group, TransDigm UK and all of TransDigm, Inc.'s
Domestic Restricted Subsidiaries. TD Group has no significant operations or
assets separate from its investment in TransDigm, Inc.
Separate financial statements of TransDigm UK are not presented because
TransDigm UK's 6.875% 2026 Notes, issued in May 2018, are fully and
unconditionally guaranteed on a senior subordinated basis by TD Group,
TransDigm, Inc. and all of TransDigm, Inc.'s Domestic Restricted Subsidiaries.
TD Group has no significant operations or assets separate from its investment in
TransDigm, Inc.
The financial information presented is that of TD Group and the Guarantors,
which includes TransDigm, Inc. and TransDigm UK, on a combined basis and the
financial information of non-issuer and non-guarantor subsidiaries has been
excluded. Intercompany balances and transactions between TD Group and Guarantors
have been eliminated, and amounts due from, amounts due to, and transactions
with non-issuer and non-guarantor subsidiaries have been presented separately.
(in millions)                                                  April 3, 2021            September 30, 2020
Current assets                                              $          4,651          $             5,398
Non-current assets                                                     9,281                        9,157
Current liabilities                                                      907                          972
Non-current liabilities                                               20,304                       20,423
Amounts due (from) to subsidiaries that are
non-issuers and non-guarantors - net                                  (1,014)                         103


                                                                          Twenty-Six Week Period Ended
(in millions)                                                                     April 3, 2021
Net sales                                                                $                      1,738
Sales to subsidiaries that are non-issuers and non-guarantors                                      12
Cost of sales                                                                                     796

Expense from subsidiaries that are non-issuers and non-guarantors - net

                                                                                              22
Income from continuing operations                                                                 147
Net income attributable to TD Group                                                               147


Certain Restrictive Covenants in Our Debt Documents
The Credit Agreement and the Indentures governing the Notes contain restrictive
covenants that, among other things, limit the incurrence of additional
indebtedness, the payment of special dividends, transactions with affiliates,
asset sales, acquisitions, mergers and consolidations, liens and encumbrances,
and prepayments of certain other indebtedness.
The restrictive covenants included in the Credit Agreement are subject to
amendments executed periodically. The most recent amendment that impacted the
restrictive covenants contained in the Credit Agreement is Amendment No. 7.
Under the terms of the Credit Agreement, TransDigm is entitled, on one or more
occasions, to request additional term loans or additional revolving commitments
to the extent that the existing or new lenders agree to provide such incremental
term loans or additional revolving commitments provided that, among other
conditions, our consolidated net leverage ratio would be no greater than 7.25x
and the consolidated secured net debt ratio would be no greater than 5.00x, in
each case, after giving effect to such incremental term loans or additional
revolving commitments.
If any such default occurs, the lenders under the Credit Agreement and the
holders of the Notes may elect to declare all outstanding borrowings, together
with accrued interest and other amounts payable thereunder, to be immediately
due and payable. The lenders under the Credit Agreement also have the right in
these circumstances to terminate any commitments they have to provide further
borrowings. In addition, following an event of default under the Credit
Agreement, the lenders thereunder will have the right to proceed against the
collateral granted to them to secure the debt, which includes our available
cash, and they will also have the right to prevent us from making debt service
payments on the Notes.
                                       43
--------------------------------------------------------------------------------
  Table of Contents
With the exception of the revolving credit facility, the Company has no
maintenance covenants in its existing term loan and indenture agreements. Under
the Credit Agreement, if the usage of the revolving credit facility exceeds 35%,
or $266 million, of the total revolving commitments, the Company is required to
maintain a maximum consolidated net leverage ratio of net debt to trailing
four-quarter EBITDA As Defined of 7.25x as of the last day of the fiscal
quarter.
As of April 3, 2021, the Company was in compliance with all of its debt
covenants and expects to remain in compliance with its debt covenants in
subsequent periods.
Trade Receivables Securitization Facility
During fiscal 2014, the Company established a trade receivable securitization
facility (the "Securitization Facility"). The Securitization Facility
effectively increases the Company's borrowing capacity depending on the amount
of the domestic operations' trade accounts receivable. The Securitization
Facility includes the right for the Company to exercise annual one year
extensions as long as there have been no termination events as defined by the
agreement. The Company uses the proceeds from the Securitization Facility as an
alternative to other forms of debt, effectively reducing borrowing costs.
On July 22, 2020, the Company amended the Securitization Facility to extend the
maturity date to July 27, 2021. As of April 3, 2021, the Company has borrowed
$350 million under the Securitization Facility, which bears interest at a rate
of 1.35%, plus 0.50% or LIBOR, whichever is greater. At April 3, 2021, the
applicable interest rate was 1.85%. The Securitization Facility is
collateralized by substantially all of the Company's domestic operations' trade
accounts receivable.
Stock Repurchase Program
On November 8, 2017, our Board of Directors, authorized a stock repurchase
program permitting repurchases of our outstanding shares not to exceed $650
million in the aggregate, subject to any restrictions specified in the Credit
Agreement and/or Indentures governing the existing Notes.
No repurchases were made under the program during the fiscal quarter ended April
3, 2021. As of April 3, 2021, the remaining amount of repurchases allowable
under the $650 million program was $631.1 million subject to any restrictions
specified in the Credit Agreement and/or Indentures governing the existing
Notes.
Off-Balance Sheet Arrangements
The Company utilizes letters of credit to back certain payment and performance
obligations. Letters of credit are subject to limits based on amounts
outstanding under the Company's revolving credit facility. As of April 3, 2021,
the Company had $39.7 million in letters of credit outstanding.
                                       44
--------------------------------------------------------------------------------
  Table of Contents
Non-GAAP Financial Measures
We present below certain financial information based on our EBITDA and EBITDA As
Defined. References to "EBITDA" mean earnings before interest, taxes,
depreciation and amortization, and references to "EBITDA As Defined" mean EBITDA
plus, as applicable for each relevant period, certain adjustments as set forth
in the reconciliations of income from continuing operations to EBITDA and EBITDA
As Defined and the reconciliations of net cash provided by operating activities
to EBITDA and EBITDA As Defined presented below.
Neither EBITDA nor EBITDA As Defined is a measurement of financial performance
under U.S. GAAP. We present EBITDA and EBITDA As Defined because we believe they
are useful indicators for evaluating operating performance and liquidity.
Our management believes that EBITDA and EBITDA As Defined are useful as
indicators of liquidity because securities analysts, investors, rating agencies
and others use EBITDA to evaluate a company's ability to incur and service debt.
In addition, EBITDA As Defined is useful to investors because the revolving
credit facility under our senior secured credit facility requires compliance
under certain circumstances, on a pro forma basis, with a financial covenant
that measures the ratio of the amount of our secured indebtedness to the amount
of our Consolidated EBITDA defined in the same manner as we define EBITDA As
Defined herein.
In addition to the above, our management uses EBITDA As Defined to review and
assess the performance of the management team in connection with employee
incentive programs and to prepare its annual budget and financial projections.
Moreover, our management uses EBITDA As Defined to evaluate acquisitions.
Although we use EBITDA and EBITDA As Defined as measures to assess the
performance of our business and for the other purposes set forth above, the use
of these non-GAAP financial measures as analytical tools has limitations, and
you should not consider any of them in isolation, or as a substitute for
analysis of our results of operations as reported in accordance with U.S. GAAP.
Some of these limitations are:
•neither EBITDA nor EBITDA As Defined reflects the significant interest expense,
or the cash requirements, necessary to service interest payments on our
indebtedness;
•although depreciation and amortization are non-cash charges, the assets being
depreciated and amortized will often have to be replaced in the future, and
neither EBITDA nor EBITDA As Defined reflects any cash requirements for such
replacements;
•the omission of the substantial amortization expense associated with our
intangible assets further limits the usefulness of EBITDA and EBITDA As Defined;
•neither EBITDA nor EBITDA As Defined includes the payment of taxes, which is a
necessary element of our operations; and
•EBITDA As Defined excludes the cash expense we have incurred to integrate
acquired businesses into our operations, which is a necessary element of certain
of our acquisitions.
Because of these limitations, EBITDA and EBITDA As Defined should not be
considered as measures of discretionary cash available to us to invest in the
growth of our business. Management compensates for these limitations by not
viewing EBITDA or EBITDA As Defined in isolation and specifically by using other
U.S. GAAP measures, such as net income, net sales and operating profit, to
measure our operating performance. Neither EBITDA nor EBITDA As Defined is a
measurement of financial performance under U.S. GAAP, and neither should be
considered as an alternative to net income or cash flow from operations
determined in accordance with U.S. GAAP. Our calculation of EBITDA and EBITDA As
Defined may not be comparable to the calculation of similarly titled measures
reported by other companies.
                                       45

--------------------------------------------------------------------------------

Table of Contents The following table sets forth a reconciliation of income from continuing operations to EBITDA and EBITDA As Defined (in millions):


                                                                 Thirteen Week Periods Ended                    Twenty-Six Week Periods Ended
                                                            April 3, 2021

March 28, 2020 April 3, 2021 March 28, 2020 Income from continuing operations

                         $          105          $           323          $         155          $          556

Adjustments:


Depreciation and amortization expense                                 66                       72                    124                     141
Interest expense, net                                                268                      252                    535                     501
Income tax provision                                                  25                       14                     28                      73
EBITDA                                                               464                      661                    842                   1,271
Adjustments:
Inventory acquisition accounting adjustments (1)                       6                        -                      6                       -
Acquisition integration costs (2)                                      5                        9                      7                      15
Acquisition transaction-related expenses (3)                           5                        -                      6                       1
Non-cash stock compensation expense (4)                               21                       11                     70                      37
Refinancing costs (5)                                                 24                        3                     24                      26
COVID-19 pandemic restructuring costs (6)                             18                        1                     39                       1
Other, net (7)                                                       (24)                     (10)                    (1)                      5
EBITDA As Defined                                         $          519          $           675          $         993          $        1,356




(1)Represents accounting adjustments to inventory associated with acquisitions
of businesses and product lines that were charged to cost of sales when the
inventory was sold.
(2)Represents costs incurred to integrate acquired businesses and product lines
into TD Group's operations, facility relocation costs and other
acquisition-related costs.
(3)Represents transaction-related costs comprising deal fees, legal, financial
and tax due diligence expenses and valuation costs that are required to be
expensed as incurred.
(4)Represents the compensation expense recognized by TD Group under our stock
incentive plans.
(5)Represents costs expensed related to debt financing activities, including new
issuances, extinguishments, refinancings and amendments to existing agreements.
(6)Represents restructuring costs related to the Company's cost reduction
measures in response to the COVID-19 pandemic ($17 million and $36 million for
the thirteen and twenty-six week periods ended April 3, 2021, respectively, and
$1 million for the the thirteen and twenty-six week periods ended March 28,
2020). These are costs related to the Company's actions to reduce its workforce
and consolidate certain facilities to align with customer demand. This also
includes $1 million and $3 million for the thirteen and twenty-six week periods
ended April 3, 2021, respectively, of incremental costs related to the pandemic
that are not expected to recur once the pandemic has subsided and are clearly
separable from normal operations (e.g., additional cleaning and disinfecting of
facilities by contractors above and beyond normal requirements, personal
protective equipment, etc.).
(7)Primarily represents the gain on insurance proceeds from the Leach
International Europe fire (Note 17), foreign currency transaction gain or loss,
payroll withholding taxes related to special dividend and dividend equivalent
payments and stock option exercises, non-service related pension costs, deferred
compensation, gain or loss on sale of fixed assets and gain or loss on sale of
businesses.
                                       46

--------------------------------------------------------------------------------

Table of Contents The following table sets forth a reconciliation of net cash provided by operating activities to EBITDA and EBITDA As Defined (in millions):

Twenty-Six Week Periods Ended


                                                                      April 3, 2021          March 28, 2020
Net cash provided by operating activities                            $         372          $          594
Adjustments:
Changes in assets and liabilities, net of effects from acquisitions
of businesses                                                                   (9)                    148
Interest expense, net (1)                                                      518                     485
Income tax provision - current                                                  28                      82
Loss contract amortization                                                      27                      25
Non-cash stock compensation expense (2)                                        (70)                    (37)
Refinancing costs (3)                                                          (24)                    (26)
EBITDA                                                                         842                   1,271
Adjustments:
Inventory acquisition accounting adjustments (4)                                 6                       -
Acquisition integration costs (5)                                                7                      15
Acquisition transaction-related expenses (6)                                     6                       1
Non-cash stock compensation expense (2)                                         70                      37
Refinancing costs (3)                                                           24                      26
COVID-19 pandemic restructuring costs (7)                                       39                       1
Other, net (8)                                                                  (1)                      5
EBITDA As Defined                                                    $         993          $        1,356




(1)Represents interest expense excluding the amortization of debt issuance costs
and premium and discount on debt.
(2)Represents the compensation expense recognized by TD Group under our stock
incentive plans.
(3)Represents costs expensed related to debt financing activities, including new
issuances, extinguishments, refinancings and amendments to existing agreements.
(4)Represents accounting adjustments to inventory associated with acquisitions
of businesses and product lines that were charged to cost of sales when the
inventory was sold.
(5)Represents costs incurred to integrate acquired businesses and product lines
into TD Group's operations, facility relocation costs and other
acquisition-related costs.
(6)Represents transaction-related costs comprising deal fees, legal, financial
and tax due diligence expenses, and valuation costs that are required to be
expensed as incurred.
(7)Represents restructuring costs related to the Company's cost reduction
measures in response to the COVID-19 pandemic ($36 million and $1 million for
the twenty-six week periods ended April 3, 2021 and March 28, 2020,
respectively). These are costs related to the Company's actions to reduce its
workforce and consolidate certain facilities to align with customer demand. This
also includes $3 million for the twenty-six week period ended April 3, 2021 of
incremental costs related to the pandemic that are not expected to recur once
the pandemic has subsided and are clearly separable from normal operations
(e.g., additional cleaning and disinfecting of facilities by contractors above
and beyond normal requirements, personal protective equipment, etc.).
(8)Primarily represents the gain on insurance proceeds from the Leach
International Europe fire (Note 17), foreign currency transaction gain or loss,
payroll withholding taxes related to special dividend and dividend equivalent
payments and stock option exercises, non-service related pension costs, deferred
compensation, gain or loss on sale of fixed assets and gain or loss on sale of
businesses.




                                       47

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses